Myeloma Treatment Guidelines Personalize Therapy For Patients

Scientists at Mayo Clinic Cancer Center have developed new suggestions to treat recently

clinically diagnosed multiple myeloma patients who are not participating in clinical trials. The

suggestions give doctors practical, easy to follow recommendations for providing initial

treatment, control cell implant and maintenance therapy. The suggestions are released in the

current issue of the publication Mayo Clinic Proceedings and signify a agreement opinion of

hematologists at Mayo Clinic Cancer Center sites in New york, Florida and Phoenix.

“Multiple myeloma is a terminal blood cancer that impacts more than 20,000 people in the U.S.

each year,” says lead author John Mikhael, M.D. a hematologist at Mayo Clinic in Arizona

“Over the past several years we have made great progress in understanding the disease,

developing drug treatments and increasing overall success. However, as a medical community

we have not done as good a job at improving treatment based on an individual's individual risk

factors 

For more informations log onto: http://www.facebook.com/pages/BestCare-Laboratory-

Services/110725332324931